Abstract: A method for recovering a desired component from a sample solution with beads under stabilized fluidized bed conditions is provided. Also provided are support beads for use in downstream processing which comprise a polymer matrix into which glass or silica particles have been incorporated.

Abstract: Support system for the synthesis of oligonucleotides wherein the first nucleoside is bound to the support via a silylether linkage, especially of the formula ##STR1## wherein B is a nucleoside or deoxynucleoside base.R.sub.1 is a protecting group.R.sub.2 is --H, --OH, or --OR.sub.5, in which R.sub.5 is a protecting group.R.sub.3, R.sub.4 and X each represent alkyl, aryl, cycloalkyl, alkenyl, aralkyl, cycloalkylalkyl, alkyloxy, aryloxy, cycloalkyloxy, alkenyloxy, aralkyloxy.S is a solid support, whereby not more than one of R.sub.3, R.sub.4 and X represent alkyloxy, aryloxy, cycloalkyloxy, alkenyloxy, aralkyloxy or cycloalkylalkyloxy.

Abstract: An ion exchanger for chromatographic separation has the structureP--S--A,wherein P is an insoluble support, S is a spacer, and A is a functional ligand. According to the invention the functional ligand A comprises two positively charged atoms, each selected from nitrogen and sulphur, at a distance of two atoms from each other, with the proviso that A can not be 4-methyl-1,4-diazabicyclo[2.2.2]octan-1-yl, 1,4,4-trimethylpiperazinium-1-yl, 1,4-dimethyl-1,4-diazabicyclo[2.2.2]octan-2-yl or 1,1,4,4,4-pentamethyl-1,4-diazabutan-1-yl.

Abstract: Protein G variants are disclosed. These protein G variants have the immunoglobulin binding properties of protein G. Also disclosed is the preparation of the protein G variants by expression from hosts transformed with a gene encoding the protein G variants.

Abstract: An apparatus for carrying out biochemical reactions in microtiter plates includes a device (42, 43) for receiving and holding microtiter plate (44) to be processed, the microtiter plate being provided with a plurality of wells and each well having a bottom outlet, and a movably mounted device (47) for the application of gas pressure to the wells of the microtiter plate (44), the pressure device including a sealing collar (48) and being movable between a position where it leaves the upper part of the microtiter plate accessible, and a position where it sealingly contacts the microtiter plate through the sealing collar (48) so that a gas pressure may be applied to the inlets of the microtiter plate wells for pressing out liquid present therein through the bottom outlet of each well.

Abstract: Protein G variants are disclosed. These protein G variants have the immunoglobulin binding properties of protein G. Also disclosed is the preparation of the protein G variants by expression from hosts transformed with a gene encoding the protein G variants.

Abstract: An apparatus for flow field flow (FFF) fractionation comprises: a porous hollow fiber (1) which extends longitudinally between end-fittings (2, 3) of a tube (4), one end of said fiber (1) being connected to a first pump (5) for pumping a first carrier liquid into said fiber (1) via a valve (9) for introducing a liquid sample to be fractionated, the other end of said fiber (1) being connected to a container for a second carrier liquid via a flow-through detector (11), for detecting fractions of said sample; a second pump (12) which is connected to the interspace between the tube (4) and the fiber (1) to pump out carrier fluid through the porous fiber wall; and a control unit (6) which is adapted to control said first pump (5) to have a flower flow rate than said second pump (12) during injection and relaxation of the sample, and a higher flow rate than said second pump (12) to elute the sample; and a method for FFF fractionation in a hollow fiber utilizing the steps of sample application, relaxation, flow rest

Abstract: Anion exchangers for chromatographic separation, containing two positive charges at a distance of two atoms from each other. The invention comtemplates in particular anion exchangers containing two quaternary amino groups.

Abstract: A hybrid DNA molecule is disclosed by this invention capable of cellular expression comprising the DNA sequence for protein G. Said DNA sequence has substantially the same IgC binding properties as naturally occurring protein G. The molecule may be comprised of DNA sequences coding for fragments of protein G. Moreover, said DNA sequence may code for both fragments of protein G and protein G. The DNA sequence can be isolated from streptococcal DNA.

Abstract: A method of producing and selectively isolating a desired protein or polypeptide or derivative thereof by constructing a recombinant vector comprising a DNA sequence coding for said desired protein or polypeptide operatively linked to a DNA sequence coding for protein A or an active polypeptide fragment thereof or any other macromolecule capable of binding to the constant regions of immunoglobulins, such that said DNA sequences together code for an IgG-binding fusion product between said desired protein or polypeptide and said protein A, active polypeptide fragment thereof or macromolecule; transforming a compatible host with said recombinant vector such that the combined DNA sequences coding for said fusion protein or polypeptide can be expressed by the host, and culturing the transformed host in a suitable growth medium to produce said fusion protein or polypeptide; selectively isolating said fusion protein or polypeptide by adsorption to an IgG-supporting carrier material; and optionally desorbing said fus

Abstract: A cloned gene encoding Protein G, or functionally active portions thereof, vectors containing the cloned gene, and microorganisms transformed by those vectors are disclosed.